Lucas G. Hill graduated from the University of Missouri-Kansas City School of Pharmacy and completed a combined family medicine residency and faculty development fellowship in the University of Pittsburgh Medical Center St. Margaret Department of Family Medicine. He is now a clinical assistant professor at The University of Texas at Austin (UT) College of Pharmacy.
Dr. Hill is Director of the Pharmacy Addictions Research & Medicine (PhARM) Program and Principal Investigator of Operation Naloxone. In this role, he manages $25 million in funding as a leader of the Texas Targeted Opioid Response. Dr. Hill has used these funds to educate more than 4,000 health professionals while distributing 68,000 doses of naloxone, the antidote for an opioid overdose. Thanks to this work, at least 2,000 Texan lives have been saved since 2017.
Dr. Hill also coordinates the first year of the UT Foundations for Interprofessional Collaborative Practice curriculum and serves as lead instructor for a module that trains students from pharmacy, medicine, nursing, and social work to provide team-based care for patients with addiction. He provides an additional 16 hours of addiction-related instruction student pharmacists and collaborates with addiction treatment providers in the Austin area to engage student pharmacists directly in clinical addiction practice.
Dr. Hill currently serves as chair-elect of the American Association of Colleges of Pharmacy Substance Use Disorder Special Interest Group. He is also faculty advisor for the UT Student Pharmacist Recovery Network and co-chair for the UT Opioid Response Consortium. In 2020, Dr. Hill was awarded the American Pharmacists Association Generation Rx Award of Excellence in recognition of his outstanding contributions to addiction-related education.